Uwell Biopharma, Inc. (TPEX:7902)
Taiwan
· Delayed Price · Currency is TWD 42.20
+2.95 (7.52%)
At close: Mar 5, 2026
Uwell Biopharma Company Description
Uwell Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel cancer immunotherapeutic in Taiwan.
The company provides chimeric antigen receptor T-cell (CAR-T) therapy platforms, lentiviral vector production, and related services.
The company was founded in 2020 and is based in New Taipei City, Taiwan.
Uwell Biopharma, Inc.
| Country | Taiwan |
| Founded | 2020 |
| Industry | Biological Products, Except Diagnostic Substances |
Contact Details
Address: Xintai 5 Road New Taipei City, 221416 Taiwan | |
| Phone | 886 2 2697 2200 |
| Website | uwell.com.tw |
Stock Details
| Ticker Symbol | 7902 |
| Exchange | Taipei Exchange |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| SIC Code | 2836 |